OncoNano is a series b startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
OncoNano is a company focused on developing products that exploit the principles of molecular cooperativity in cancer. Their lead development program utilizes a novel micelle technology for dual enhanced fluorescence guided surgery and systemic chemotherapy.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky